Colin Edwards, CEO of Merlin Consulting, a consulting firm providing services to the pharma, life sciences and digital health sectors in Ireland, discusses his reasons for leaving Boehringer Ingelheim to set up the company, his thoughts on the digital health landscape in Ireland, and the challenges that he foresees.
We met you four years ago as the Country Manager for Boehringer Ingelheim. What made you decide to start your own pharma consulting company, Merlin Consulting?
"Ireland is a small market so pharma companies may not wish to bring in a dedicated medical affairs person for just one product for the pre- and post-launch period, so this is where we could step in."
